Yehuda Folberg

April Trendletter

“Escala Medical receives FDA… Arcuro appoints SAB Chair… AFIC’s Pitch Day…”

Escala Medical receives FDA regulatory clearance

First in Human clinical study completed. Internationally renowned urogynecologist and pelvic surgeon, Mickey Karram M.D. joins Scientific Advisory Board

The Trendlines Group | March 2022

“Trendlines’ FY2021 Annual Report… Phytolon and Ginkgo Bioworks collaborate… Israel Agrifood week…”

Phytolon and Ginkgo Bioworks collaborate to take biological production of vibrant food colors to the next level

The companies seek to leverage cell programming to produce betalain pigments across the full yellow-to-purple spectrum

The Trendlines Group | February 2022

“Vensica raises $19 million… SetBone raises…  PresenTense & Trendlines collaborate…”

Vensica closes $19 million round with investment from strategic partner Merz

Vensica is unlocking the potential of neurotoxins in urology by developing minimally invasive solutions…

SetBone Medical announces $1.6 million financing

SetBone Medical has developed a novel bone cement for the treatment of spinal vertebrae fractures and …

The Trendlines Group | January 2022

“FruitSpec raises… AgroScout acquires… Trendlines 2021 achievements…”

Breakthrough in device therapy for patients with late-stage heart disease

Calon Cardio-Technology Ltd. and Leviticus-Cardio announced the joint Development and Testing of a Wireless, Fully Implantable, Long-Term Blood Pump.

Trendlines invests in agri-fintech company AgriG8

Smallholder and family scale farms are the backbone of our global food system, yet many of them do not have access to financing …